The interaction of graphene oxide nanoparticles with human peripheral blood mononuclear cells was studied using the Cell-IQ continuous monitoring system for living cells. We used graphene oxide nanoparticles of various sizes coated with linear or branched polyethylene glycol (PEG) in concentrations of 5 and 25 μg/ml. After 24-h incubation with graphene oxide nanoparticles, the increase in the number of peripheral blood mononuclear cells at visualization points decreased; nanoparticles coated with branched PEG more markedly suppressed cell growth in culture. In the presence of graphene oxide nanoparticles, peripheral blood mononuclear cells retained high viability in culture after daily monitoring in the Cell-IQ system. The studied nanoparticles were engulfed by monocytes and the type of PEGylation had no effect on this process. Thus, graphene oxide nanoparticles reduced the increase in peripheral blood mononuclear cell mass during dynamic observation in the Cell-IQ system without reducing their viability.
Similar content being viewed by others
References
Dasari Shareena TP, McShan D, Dasmahapatra AK, Tchounwou PB. A review on graphene-based nanomaterials in biomedical applications and risks in environment and health. Nanomicro Lett. 2018;10(3):53. https://doi.org/10.1007/s40820-018-0206-4
Raslan A, Saenz Del Burgo L, Ciriza J, Pedraz JL. Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. Int. J. Pharm. 2020;580:119226. https://doi.org/10.1016/j.ijpharm.2020.119226
Makharza S, Cirillo G, Bachmatiuk A, Ibrahim I, Ioannides N, Trzebicka B, Hampel S, Rümmeli MH. Graphene oxide-based drug delivery vehicles: functionalization, characterization, and cytotoxicity evaluation. J. Nanopart. Res. 2013;15(12):2099. https://doi.org/10.1007/s11051-013-2099-y
Park MVDZ, Bleeker EAJ, Brand W, Cassee FR, van Elk M, Gosens I, de Jong WH, Meesters JAJ, Peijnenburg WJGM, Quik JTK, Vandebriel RJ, Sips AJAM. Considerations for safe innovation: the case of graphene. ACS Nano. 2017;11(10):9574-9593. https://doi.org/10.1021/acsnano.7b04120
Ou L, Lin S, Song B, Liu J, Lai R, Shao L. The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis. Int. J. Nanomedicine. 2017;12:6633-6646. https://doi.org/10.2147/IJN.S140526
de Melo-Diogo D, Lima-Sousa R, Alves CG, Costa EC, Louro RO, Correia IJ. Functionalization of graphene family nanomaterials for application in cancer therapy. Colloids Surf. B Biointerfaces. 2018;171:260-275. https://doi.org/10.1016/j.colsurfb.2018.07.030
Cao W, He L, Cao W, Huang X, Jia K, Dai J. Recent progress of graphene oxide as a potential vaccine carrier and adjuvant. Acta Biomater. 2020;112:14-28. https://doi.org/10.1016/j.actbio.2020.06.009
Liu Z, Robinson JT, Sun X, Dai H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 2008;130(33):10876-10877. https://doi.org/10.1021/ja803688x
Zhao R, Lv M, Li Y, Sun M, Kong W, Wang L, Song S, Fan C, Jia L, Qiu S, Sun Y, Song H, Hao R. Stable nanocomposite based on PEGylated and silver nanoparticles loaded graphene oxide for long-term antibacterial activity. ACS Appl. Mater. Interfaces. 2017;9(18):15328-15341. https://doi.org/10.1021/acsami.7b03987
Dudek I, Skoda M, Jarosz A, Szukiewicz D. The molecular influence of graphene and graphene oxide on the immune system under in vitro and in vivo conditions. Arch. Immunol. Ther. Exp. (Warsz). 2016;64(3):195-215. https://doi.org/10.1007/s00005-015-0369-3
Feito MJ, Vila M, Matesanz MC, Linares J, Gonçalves G, Marques PA, Vallet-Regí M, Rojo JM, Portolés MT. In vitro evaluation of graphene oxide nanosheets on immune function. J. Colloid Interface Sci. 2014;432:221-228. https://doi.org/10.1016/j.jcis.2014.07.004
Zare P, Aleemardani M, Seifalian A, Bagher Z, Seifalian AM. Graphene oxide: opportunities and challenges in biomedicine. Nanomaterials (Basel). 2021;11(5):1083. https://doi.org/10.3390/nano11051083
Khramtsov P, Bochkova M, Timganova V, Nechaev A, Uzhviyuk S, Shardina K, Maslennikova I, Rayev M, Zamorina S. Interaction of graphene oxide modified with linear and branched PEG with monocytes isolated from human blood. Nanomaterials (Basel). 2021;12(1):126. https://doi.org/10.3390/nano12010126
Mendes RG, Koch B, Bachmatiuk A, Ma X, Sanchez S, Damm C, Schmidt OG, Gemming T, Eckert J, Rümmeli MH. A size dependent evaluation of the cytotoxicity and uptake of nanographene oxide. J. Mater. Chem. B. 2015;3(12):2522-2529. https://doi.org/10.1039/c5tb00180c
Santos JL, Montes MJ, Gutiérrez F, Ruiz C. Evaluation of phagocytic capacity with a modified flow cytometry technique. Immunol. Lett. 1995;45(1-2):1-4. https://doi.org/10.1016/0165-2478(94)00180-y
Singh SK, Singh MK, Nayak MK, Kumari S, Grácio JJ, Dash D. Characterization of graphene oxide by flow cytometry and assessment of its cellular toxicity. J. Biomed. Nanotechnol. 2011;7(1):30-31. https://doi.org/10.1166/jbn.2011.1186
Orecchioni M, Bedognetti D, Newman L, Fuoco C, Spada F, Hendrickx W, Marincola FM, Sgarrella F, Rodrigues A.F, Ménard-Moyon C, Cesareni G, Kostarelos K, Bianco A, Delogu LG. Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells. Nat. Commun. 2017;8(1):1109. https://doi.org/10.1038/s41467-017-01015-3.
Mendes RG, Mandarino A, Koch B, Meyer AK, Bachmatiuk A, Hirsch C, Gemming T, Schmidt OG, Liu Z, Rümmeli MH. Size and time dependent internalization of label-free nano-graphene oxide in human macrophages. Nano Res. 2017;10(6):1980-1995. https://doi.org/10.1007/s12274-016-1385-2
Yan J, Chen L, Huang CC, Lung SC, Yang L, Wang WC, Lin PH, Suo G, Lin CH. Consecutive evaluation of graphene oxide and reduced graphene oxide nanoplatelets immunotoxicity on monocytes. Colloids Surf. B Biointerfaces. 2017;153:300-309. https://doi.org/10.1016/j.colsurfb.2017.02.036
Uzhviyuk SV, Bochkova MS, Timganova VP, Khramtsov PV, Shardina KY, Kropaneva MD, Nechaev AI, Raev MB, Zamorina SA. Interaction of Human Dendritic Cells with Graphene Oxide Nanoparticles In Vitro. Bull. Exp. Biol. Med. 2022;172(5):664-670. https://doi.org/10.1007/s10517-022-05451-0
Zamorina SA, Khramtsov PV, Rayev MB, Timganova VP, Bochkova MS, Nechaev AI, Shunkin EO, Khaziakhmatova OG, Malaschenko VV, Litvinova LS. Graphene Oxide Nanoparticels Interaction with Jurkat Cell Line in Cell-IQ System. Dokl. Biochem. Biophys. 2021;501(1):438-443. https://doi.org/10.1134/S1607672921060089
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 62-68, March, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Uzhviyuk, S.V., Khramtsov, P.V., Raev, M.B. et al. Interaction of Graphene Oxide Nanoparticles with Human Mononuclear Cells in the Cell-IQ System. Bull Exp Biol Med 175, 172–178 (2023). https://doi.org/10.1007/s10517-023-05830-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05830-1